Molecular and pharmacological mechanisms of gupercoagulation stimulation by means of peropal and transdermal estrogen forms
- Authors: Gromova OA1,2, Torshin IY.1,2, Tetruashvili NK3, Limanova OA1,2, Serov VN4
-
Affiliations:
- ГБОУ ВПО Ивановская государственная медицинская академия Минздрава России
- РСЦ института микроэлементов ЮНЕСКО
- ФГБУ Научный центр акушерства, гинекологии и перинатологии им. акад. В.И.Кулакова Минздрава России, Москва
- Российское общество акушеров-гинекологов
- Issue: Vol 16, No 2 (2014)
- Pages: 22-28
- Section: Articles
- URL: https://ogarev-online.ru/2079-5831/article/view/28301
- ID: 28301
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
O A Gromova
ГБОУ ВПО Ивановская государственная медицинская академия Минздрава России; РСЦ института микроэлементов ЮНЕСКО
Email: Unesco.gromova@gmail.com
д-р мед. наук, проф. каф. фармакологии и клин. фармакологии ГБОУ ВПО ИвГМА, зам. дир. по науч. работе РСЦ ИМ ЮНЕСКО
I Yu Torshin
ГБОУ ВПО Ивановская государственная медицинская академия Минздрава России; РСЦ института микроэлементов ЮНЕСКОканд. физ.-хим. наук, доц. каф. фармакологии и клин. фармакологии ГБОУ ВПО ИвГМА, ст. науч. сотр. РСЦ ИМ ЮНЕСКО
N K Tetruashvili
ФГБУ Научный центр акушерства, гинекологии и перинатологии им. акад. В.И.Кулакова Минздрава России, Москвад-р мед. наук, рук. 2-го акушерского отд-ния патологии беременности
O A Limanova
ГБОУ ВПО Ивановская государственная медицинская академия Минздрава России; РСЦ института микроэлементов ЮНЕСКОканд. мед. наук, доц. каф. фармакологии и клин. фармакологии ГБОУ ВПО ИвГМА, ст. науч. сотр. РСЦ ИМ ЮНЕСКО
V N Serov
Российское общество акушеров-гинекологовакад. РАМН, д-р мед. наук, проф., засл. деят. науки РФ, президент Российского общества акушеров-гинекологов
References
- Gomes M.P, Deitcher S.R. Risk of venous thromboembolic disease associated with hormonal contraceptives and hormone replacement therapy: a clinical review. Arch Intern Med 2004; 164 (18): 1965-76.
- Hulley S, Furberg C, Barrett-Connor E et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy: Heart and Estrogen/progestin Replacement Study follow - up (HERS II). JAMA 2002; 288 (1): 58-66.
- Lidegaard O, Edstrom B, Kreiner S. Oral contraceptives and venous thromboembolism. A case - control study. Contraception 1998; 57 (5): 291-301.
- Laliberte F, Duh M.S, Kahler K.H et al. Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen - only hormone therapy. Menopause 2011; 18 (10): 1052-9.
- Shufelt C.L, Merz C.N, Prentice R.L, Pettinger M.B. Hormone therapy dose, formulation, route of delivery, and risk of cardiovascular events in women: findings from the Women's Health Initiative Observational Study. Menopause 2013; 1: 15-27.
- Sweetland S, Beral V, Balkwill A et al. Venous thromboembolism risk in relation to use of different types of postmenopausal hormonetherapy in a large prospective study. J Thromb Haemost 2012; 101111/j1538- 10111.
- Torshin I.Yu. Sensing the change from molecular genetics to personalized medicine. Nova Biomedical Books, NY, USA, 2009. In «Bioinformatics in the Post-Genomic Era» series.
- Krieg A.J, Krieg S.A, Ahn B.S, Shapiro D.J. Interplay between estrogen response element sequence and ligands controls in vivo binding of estrogen receptor to regulated genes. J Biol Chem 2004; 279 (6): 5025-34.
- Jegga A.G, Chen J, Gowrisankar S et al. GenomeTrafac: awhole genome resource for the detection of transcription factor binding site clusters associated with conventionaland microRNA encoding genes conserved between mouse and human gene orthologs. Nucleic Acids Res 2007; 35 (Databas: D116-21).
- Stepanova M, Lin F, Lin V.C. Establishing a statistic model for recognition of steroid hormone response elements. Comput Biol Chem 2006; 30 (5): 339-47.
- Lowe G.D. Hormone replacement therapy: prothrombotic vs. protective effects. Pathophysiol Haemost Thromb 2002; 32 (5-6): 329-32.
- Borgfeldt C, Samsioe G. Low - dose oral combination of 17beta - estradiol and norethisterone acetate in postmenopausal women decreases factor VII, fibrinogen, antithrombin and plasminogen activator inhibitor-1. Climacteric 2004; 7 (1): 78-85.
- Zhao Y.Y, Sun K.L, Ashok K. Analysis of a cis-Acting Element Involved in Regulation by Estrogen of Human Angiotensinogen Gene Expression. Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai) 1998; 30 (5): 445-8.
- Zhang X, Bhavnani B.R, Tam S.P. Regulation of human apolipoprotein A-I gene expression by equine estrogens. J Lipid Res 2001; 42 (11): 1789-800.
- Rickard D.J, Bonde S.K. Bone morphogenetic protein-6 production in human osteoblastic cell lines. Selective regulation by estrogen. J Clin Invest 1998; 101 (2): 413-22.
- Kanda N, Watanabe S. 17-beta - estradiol stimulates the growth of human keratinocytes by inducing cyclin D2 expression. J Invest Dermatol 2004; 123 (2): 319-28.
- Tamura M, Deb S, Sebastian S et al. Estrogen up - regulates cyclooxygenase-2 via estrogen receptor in human uterine microvascular endothelial cells. Fertil Steril 2004; 81 (5): 1351-6.
- Tsuchiya Y, Nakajima M, Kyo S et al. Human CYP1B1 is regulated by estradiol via estrogen receptor. Cancer Res 2004; 64 (9): 3119-25.
- Chen C.C, Lee W.R, Safe S. Egr-1 is activated by 17beta - estradiol in MCF- 7 cells by mitogen - activated protein kinase - dependent phosphorylation of ELK-1. J Cell Biochem 2004; 93 (5): 1063-74.
- Kleinert H, Euchenhofer C, Ihrig-Biedert I et al. Estrogens increase transcription of the human endothelial NO synthase gene: analysis of the transcription factors involved. Hypertension 1998; 31 (2): 582-8.
- Lopez D, Sanchez M.D, Shea-Eaton W, Mc Lean M.P. Estrogen activatest - hehigh - density lipoprotein receptorgenevia binding toestrogenresponse elements and interactionwith sterol regulatory elementbindingprotein-1A. Endocrinology 2002; 143 (6): 2155-68.
- Seely J, Amigh K.S, Suzuki T. Transcriptional regulation of dehydroepi - androsteronesulfotransferase (SULT2A1) by estrogen - related receptor alpha. Endocrinology 2005; 146 (8): 3605-13.
- Reddy Kilim S, Chandala S.R. A comparative study of lipid profile and oestradiol in pre - and post - menopausal women. J Clin Diagn Res 2013; 7 (8): 1596-8 doi.
- Maximov P.Y, Lee T.M, Jordan V.C. The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practice. Curr Clin Pharmacol 2013; 8 (2): 135-55.
- Citarella F, Felici A, Farsetti A, Pontecorvi A, Fantoni A. Estrogen induction and contact phase activation of human factor XII. Steroids 1996; 61 (4): 270-6.
- Громова О.А., Торшин И.Ю., Лиманова О.А. и др. Сравнительное исследование доказательной базы эффективности и безопасности применения пероральной и трансдермальной форм заместительной гормональной терапии эстрогенами у женщин в различные возрастные периоды. Проблемы репродукции. 2013; 6: 86-96.
- Travassos de Figueiredo Alves, Amelia Sobreira Gomes M, Clapauch R. Comparison of gel and patch estradiol replacement in Brazil, a tropical country. Maturitas 2000; 36 (1): 69-74.
- Wells B.J, Kattan M.W, Cooper G.S et al. ColoRectal Cancer Predicted Risk Online (CRC-PRO) Calculator Using Data from the Multi-Ethnic Cohort Study. J Am Board Fam Med 2014; 27 (1): 42-55.
- Gingras D, Béliveau R. Colorectal cancer prevention through dietary and lifestyle modifications. Cancer Microenviron 2011; 4 (2): 133-9.
- Coyne M.J, Bonorris G.G, Chung A et al. Estrogen enhances dietary cholesterol induction of saturated bile in the hamster. Gastroenterology 1978; 75 (1): 76-9.
- Громова О.А., Торшин И.Ю., Лиманова О.А. Сравнительное исследование доказательной базы эффективностии безопасности применения пероральной и трансдермальной форм заместительной гормональной терапии эстрогенами у женщин в различные возрастные периоды. Проблемы репродукции. 2013; 6: 86-96.
- Jarvinen A, Granander M, Nykanen S et al. Steady - state pharmacokinetics of oestradiol gel in post - menopausal women: effects of application area and washing. Br J ObstetGynaecol 1997; 104 (Suppl.): 14-8.
Supplementary files
